Halma plc ('Halma')
2022 Annual General Meeting - Voting Results Update Statement
At the Company's Annual General Meeting ("AGM") held on 21 July 2022, the total votes received in favour of Resolution 3 (Remuneration Report) was 67.14%. The total votes received in favour of Resolution 10 (the re-election of Jo Harlow, as a director) was 76.78%, and we understand from shareholders that this was linked to her role as Remuneration Committee Chair.
Given more than 20 per cent of votes were cast against these Resolutions, the Company is providing an update on the views received from shareholders and actions taken as set out under the provisions of the UK Corporate Governance Code.
Since the AGM, we have completed a thorough shareholder engagement, outlining Halma's continuing strong profit and valuation growth over the past twenty years, as well as clarifying that retention risk was part of the rationale for the variable pay and salary reset implemented over two years, in 2021 and 2022.
The benefits of this reset were demonstrated during the period. As part of a well-planned CEO transition process over the past 12 months, Halma was able to successfully recruit an experienced FTSE 100 Group CFO, Steve Gunning, to replace Marc Ronchetti, who will be promoted to the Group CEO with effect from 1 April 2023. No further future changes were raised or requested by the shareholders with whom we met.
The Board would like to thank all the shareholders that have taken part in the engagement and for the feedback provided. In line with our normal practice, the Board will continue to engage with shareholders and their representative bodies and will provide a final update in the 2023 Directors' Remuneration Report.
For further information, please contact: |
|
Mark Jenkins Company Secretary, Halma plc Tel: +44 (0)1494 721111 |
|
About Halma
Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner, healthier future for everyone, every day. Its purpose defines the three broad market areas where it operates:
·
Safety - Protecting people's safety and the environment as populations grow, and enhancing worker safety
·
Environment - Addressing the impacts of climate change, pollution and waste, protecting life-critical resources and supporting scientific research
· Health - Meeting the increasing demand for better healthcare as chronic illness rises, driving by growing and ageing populations and lifestyle changes.
It employs over 7,000 people in more than 20 countries, with major operations in the UK, Mainland Europe, the USA and Asia Pacific. Halma is listed on the London Stock Exchange (LON: HLMA) and is a constituent of the FTSE 100 index.